Leukemia Research
Volume 24, Issue 7 , Pages 631-635 , July 2000

Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia

Received 18 January 2000 ,Accepted 7 March 2000.

References 

  1. Clarkson BD, Strif A, Wisniewski D, Labek C, Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 1997;11:1404–1428
  2. Verfaille C. Biology of chronic myelogenous leukemia. Hematol Oncol Clin North Am. 1998;12:1–15
  3. Goldman JM. Chronic myeloid leukemia. Curr. Opin. Hematol. 1997;4:277–285
  4. O’Brien S, Thall PF, Siciliano MJ. Cytogenetics of chronic myelogenous leukemia. Bailliere Hematol. 1997;10:259–276
  5. Sawyers CL. Chronic myeloid leukemia. New Engl. J. Med. 1999;340:1330–1340
  6. Enright H, McGlave PB. Chronic myelogenous leukemia. Curr. Opin. Hematol. 1996;3:303–309
  7. Mitelman F. The cytogenetic scenario of chronic myeloid leukemia. Leuk. Lymphoma. 1993;11:11–15
  8. Van Etten RA. The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy. In:  Freireich EJ,  Kantadian H editor. Leukemia: Advances Research and Treatment. New York: Kluwer Academic Publishers; 1993;p. 295–325
  9. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93–99
  10. Melo JV. The molecular biology of chronic myeloid leukemia. Leukemia. 1996;10:751–756
  11. Cortes JE, Talpaz M, Kantadian H. Chronic myelogenous leukemia: a review. Am. J. Med. 1996;100:555–570
  12. Van der Plas DC, Grosveld G, Hagemeijer A. Review of clinical, cytogenetics, and molecular aspects of Ph-negative CML. Cancer Genet. Cytogenet. 1991;52:143–156
  13. Mills KI, Mackenzie ED, Birnie GD. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML, patients. Blood. 1988;72:1237–1241
  14. Fioretos T, Nilsson PG, Aman P, Heim S, Kristoffersson U, Malm Q, et al.  Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia. Leukemia. 1993;7:1225–1231
  15. Van der Plas DC, Hermans ABC, Sockarman D, Smit EME, de Klein A, Smadja N, et al.  Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 1989;73:1038–1044
  16. Saglio G, Pane F, Martinelli G, Guerraasio A. BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle. Leuk. Lymphoma. 1997;26:281–286
  17. Meissner RD, Dias PMB, Covas DT, Job F, Leite M, Nardi NB. A polymorphism. in exon b2 of the major breakpoint cluster region (M-bcr) identified in chronic myeloid leukemia patients. Br. J. Haematol. 1998;103:224–226
  18. Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion gene in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92:3362–3367
  19. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88:2375
  20. Van Rhee F, Hochhaus A, Lin F, Melo V, Goldman M, Cross NC. p109 BCR/ABL mRNA is expressed at low level in p210-positive chronic myeloid and acute lymphoblastic leukemia. Blood. 1996;87:5213–5217
  21. Dhingra K, Talpaz M, Kantarjian HM, Ku S, Rothberg J, Gutterman JU, et al.  Appearance of acute leukemia-associated p190 BCR-ABL in chronic myleloid leukemia may correlate with disease progression. Leukemia. 1991;5:191
  22. Martinelli G, Chiamenti A, Gasparini P, et al.  BCR breakpoint sub-regions and blast crisis lineage in CML patients. Blood. 1988;72:1237–1241
  23. Rozman C, Urbano-Ispizua A, Cervantes F, et al.  Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia. Leukemia. 1995;9:1104–1107
  24. Fioretos T, Nilsson PG, Aman P, et al.  Clinical impact of breakpoint position with M-bcr in chronic myeloid leukemia. Leukemia. 1993;7:1225–1231
  25. Melo JV, Hochhaus A, Yan XH, Golman JM. Lack of correlation between ABL-BCR expression and response interferon-alpha in chronic myeloid leukemia. Br. J. Haematol. 1996;92:684–686
  26. Melo JV, Gordon DE, Tuszyrtski A, et al.  Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia. Blood. 1993;81:2488–2491
  27. Chissoe SL, Bodenteich A, Wang YF, et al.  Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics. 1995;27:67–82
  28. Mittre H, Leymarie P, Macro M, Leporrier M. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL Junction. Is it really a distinct disease?. Blood. 1996;88:4239–4240
  29. Macera MJ, Szabo P, Lin JH, DeSalvo AT, Shah OH, Verma RS. Direct visualization of the transposed ABL gene in a duplicated masked Ph chromosome. Gene, Chromosomes Cancer. 1993;8:127–130
  30. Sinclair PB, Green AP, Grace C, Nacheva EP. Improved sensitivity of BCR-ABL detection: a triple probe three-color fluorescence in situ hybridization system. Blood. 1997;90:1395–1402
  31. Otazu IB, Zalcberg I, Tabak DG, Seuánez HN. Detection of BCR-ABL transcripts in chronic myeloid leukemia by nested PCR. Leuk Res 1999;185-190.
  32. Preudhomme C, Revillion F, Merlat A, Homez L, Rournier C, Duflos-Grardel N, et al.  Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR essay. Leukemia. 1999;13:957–964
  33. Nogva HK, Evensen SA, Madshus IH. one tube multiplex RT-PCR of BCR-ABL transcripts in analysis of patients with chronic myeloid leukemia and acute lymphoblastic leukemia. Scand. J. Clin. Lab. Invest. 1998;58:647–654
  34. Morris C, Kennedy M, Heisterkamp N, et al.  A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Gene, Chromosome Cancer. 1991;3:263–271
  35. Costello R, Sainty D, Lafage-Pochitaloff M, Gabert J. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia. Leuk Lymphoma. 1997;25:225–232
  36. Sandberg AA. The cytogenetics of chronic myelocytic leukemia (CML): chronic phase and blastic crisis. Cancer Genet. Cytogenet. 1980;1:217
  37. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature. 1983;306:277–280
  38. Kantadjan HM, Keating MJ, Walters , McCredie KB, et al.  Clinical and prognostic features of Philadelphia chromosome negative chronic myelogenous leukemia. Cancer. 1986;58:2023–2030
  39. Pugh WC, Pearson M, Vardeman JW, Rowley JD. Philadelphia chromosome-negative chronic myelogenous leukemia. A morphological reassessment. Br. J. Haematol. 1985;60:457–467
  40. Kurzrock R, Talpaz M. The molecular pathology of chronic myelogenous leukemia. Br. J. Haematol. 1991;79:34–37
  41. Pasternak G, Hochhaus A, Schultheis B, HehImann R. Chronic myelogenous leukemia: molecular and cellular aspects. J. Cancer Res. Clin. Oncol. 1998;124:643–660
  42. Martiat P, Michaux JL, Rodhain J. Philadelphia-negative (Ph-) chronic myeloid leukemia: Comparison with Ph+ CML and chronic myelomonocytic leukemia. Blood. 1991;78:205–211
  43. Hooberman AL, Westbrook CA. Molecular methods to detect the Philadelphia chromosome. Clin. Lab. Med. 1990;10:839–855
  44. Cox MC, Maffel L, Buffolino S, et al.  A comparison analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl positive leukemia. Am. J. Clin. Path. 1998;109:24–31
  45. Chen Z, Morgan R, Berger CS, et al.  Identification of masked and variant (complex type) translocations in CML and classic Ph in AML, and ALL by fluorescence in situ hybridization with use of bcr/abl cosmid probe. Cancer Genet. Cytogene. 1993;70:103–107
  46. Dewald GW, Schad CR, Christensen ER, et al.  The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML, and ALL. Cancer Genet. Cytogenet. 1993;71:7–14
  47. Reider H, Bonwetsch C, Janssen LAJ, et al.  High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia. 1998;12:1473–1481
  48. Grand FH, Chase A, Iqbal S, et al.  A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia. Genes, Chromosomes, Cancer. 1998;23:109–115
  49. Nacheva E, Holloway T, Brown K, Bloxham D, et al.  Philadelphia-negative chronic myeloid leukemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22. Br. J. Haematol. 1993;87:409–412
  50. Hagemeijer A, Buijs A, Smit E, et al.  Traslocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two-negative, BCR-positive patients with chronic myeloid leukemia. Genes, Chromosomes, Cancer. 1993;8:237–245
  51. Mohamed AN, Koppitch F, Verterasian M, Karanes C, Yao K-L, Sarkar FH, et al.  BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with masked Ph chromosome. Genes, Chromosomes, Cancer. 1995;13:133–137
  52. Abeliovich D, Yehuda O, Krichevsky S, et al.  Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia. Cancer Genet. Cytogenet. 1995;81:115–117
  53. Brunel V, Saintly D, Costello R, et al.  Translocation of BCR to chromosome in a Philadelphia-negative chronic myeloid leukemia. Cancer Genet. Cytogenet. 1995;85:82–84
  54. Aurich J, Dastugue N, Duchayne E, Schlaifer D, et al.  Locationof the BCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia. Gene, Chromosomes Cancer. 1997;20:148–154
  55. Hsu W-T, Preisler H, Szego K, Sprudzs R, Gao X-Z. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: A case for vigilance in fluorescence in situ hybridization interpretation. Cancer Genet. Cytogene. 1998;104:57–60
  56. Abruzzese E, Pettenati MJ, Cox K, et al.  Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases. Cancer Genet. Cytogenet. 1998;105:164–167
  57. Macera MJ, Smith W, Frankel E, Szabo P, Verma RS, et al.  A Philadelphia negative chronic myelogenous leukemia with chimeric BCR/ABL gene on chromosome 9 and B3-a2 splice junction. Cancer Genet. Cytogenet. 1998;101:143–147
  58. Reddy KS, Grove B, et al.  A Philadelphia-negative chronic myeloid leukemia with a BCR/ABL fusion gene on chromosome 9. Cancer Genet. Cytogenet. 1998;107:48–50
  59. Zhang Y, Weber-Matthiesen K, Schoch R, Schlegelberger B, et al.  Variant Philadelphia translocation t(9; 17) (q34.2-3; q21.3) with colocalization of the BCR and ABL genes on chromosome 9 in chronic mycloid leukemia. Cancer Genet. Cytogenet. 1997;96:87–89
  60. Bennet JM, Catovsky D, Daniel MT, et al.  The chronic myeloid leukemia-guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposal for the French–American–British Cooperative Leukemia Group. Br. J. Haematol. 1994;87:746–754
  61. Kantarijian HM, Deisseroth A, Kurzrock R, et al.  Chronic myeloid leukemia. A concise update. Blood. 1993;82:691–703
  62. Butturini A, Arlinghaus RB, Gale RP. Concise report BCR/ABL and leukemia. Leuk. Res. 1996;20:523–529
  63. Weidermann LM, Karhi KK, Shivji MKK, et al.  The correlation of breakpoint cluster region rearrangement and p210 Ph/abl expression with morphological analysis of-Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood. 1988;71:349–355
  64. Abe S, Minamihisamatu M, Ishihara T, Sasaki M. Chromosomal in situ hybridization and southern blot analysis using C-abl, C-sis or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations. Cancer Genet. Cytogenet. 1989;38:61–74
  65. Bartram CR, Kleihauer E, de Klein A, et al.  C-abl and ber are rearranged in a Ph-negative CML patient. EMBO J. 1985;4:683–686
  66. Calabrese G, Stuppia L, Franchi PG, et al.  Complex translocations of the Ph chromosome and Ph-negative CML, arise from similar mechanisms as evidenced by FISH analysis. Cancer Genet. Cytogenet. 1994;78:153–159
  67. Poulain S, Daudignon A, Le Baron F, Bisiau H, Simon M, Duthilleul P. Amplification of BCR-ABL rearrangement in atypical Philadelphia chromosome: a new variant detected by fluorescence in situ hybridization in one cases of acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 1999;106:158–161
  68. Benn PA. The role of the BCR/ABL oncogene in human leukemias. In:  Verma RS editors. Advances in Genome Biology: Genetics of Human Neoplasia. 3B:Greenwich, CT: JAI Press; 1995;p. 305–335
  69. Estop AM, Sherer C, Cieply K, Groft D, Burcoglu A, Jhanwar S, et al.  Ph-negative chronic myeloid leukemia patient with non-classical BCR-ABL rearrangement-characterized by fluorenscence in situ hybridization. Cancer Genet. Cytogenet. 1997;96:174–176
  70. Rasool F, Martiat P, Taj A, Klisak I, Goldman J. Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML. Leukemia. 1990;4:273–277
  71. Hochhasu A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, et al.  A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia negative chronic myelogenous leukemia. Blood. 1996;88:2236
  72. Rowley JD. The critical role of chromosome translocations in human leukemia. 1998;32:495–520.
  73. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, et al.  Large deletions at the t(9;22) breakpoint are common and may identify a poor prognosis subgroup of patients with chronic myeloid leukemia. Blood. 2000;95:738–744
  74. Faderl S, et al.  Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?. Blood. 1999;93:2755–2759
  75. Balatzenko G, et al.  Light microscopic detection of BCR-ABL transcripts after in-cell RT-PCR: fusion gene expression might correlate with clinical evolution of chronic myeloid leukemia. Leuk. Lymphoma. 2000;36:383–396

PII: S0145-2126(00)00034-5

Leukemia Research
Volume 24, Issue 7 , Pages 631-635 , July 2000

Article Tools

* Image Usage & Resolution